Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
about
Analysis of research output parameters: density equalizing mapping and citation trend analysisChemotherapy and surgery versus surgery alone in non-small cell lung cancer2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancerMulticenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease).Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients.The long-term prognosis of induction chemotherapy followed by surgery for N2 non-small cell lung cancer: A retrospective case series study.Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trialRole of multimodality treatment for lung cancer.The role of induction therapy in the management of resectable non-small cell lung cancer.The Role of Neoadjuvant Trials in Drug Development for Solid Tumors.New strategies in the treatment of resectable non-small cell lung cancer.Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.Does pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer?Adjuvant therapy for resected non-small cell lung cancerChemotherapy of lung cancer: A global perspective of the role of ifosfamideLevels of evidence and grades of recommendations in general thoracic surgery.Combined modality treatment of non-small-cell lung cancer.Gemcitabine (Gemzar) in non-small cell lung cancer.Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.Therapeutic targeting of receptor tyrosine kinases in lung cancer.Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the PrognosisEvolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisalAdding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapyComputed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non-small-cell lung cancer after neoadjuvant chemotherapy.Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study.Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N(2) non-small cell lung cancerClinical outcomes with perioperative chemotherapy in sarcomatoid carcinomas of the lung.Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancerWhat is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?Perioperative outcomes and lymph node assessment after induction therapy in patients with clinical N1 or N2 non-small cell lung cancerPreoperative concurrent radiochemotherapy and surgery for stage IIIA non-small cell lung cancer.Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.Therapeutic management options for stage III non-small cell lung cancer.Current status of induction treatment for N2-Stage III non-small cell lung cancer.Time-to-event endpoints in operable non-small-cell lung cancer randomized clinical trials.The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis.A phase II study of weekly paclitaxel, cisplatin and concurrent radiation therapy for locally-advanced unresectable non-small cell lung cancer: early closure due to lack of efficacy.Sarcomatoid carcinoma of the lung: a rare histological subtype of non-small cell lung cancer with a poor prognosis even at earlier tumour stages.Quality of life issues in non-small cell lung cancer.
P2860
Q21558544-4E57D7B9-B31B-4981-9151-FC3AB29CE0C1Q24244191-3BCDAA21-B1E7-42F7-968D-12B0E340803EQ27002509-4F2CEF35-1CDB-47A4-AEDE-2AEE3F910AF4Q33372250-EEB104D2-62B0-4580-8B07-CAA912C5DDE2Q33568631-78C40888-E54F-4210-8D86-E46F20197B49Q33613087-A59D981E-4E06-4F2C-B64F-26F3C7B28B4AQ33813436-E2188221-001A-42C1-B31B-C5578E667443Q33829263-F319F4FD-F7C2-40FA-8EF5-2C2CCFF399B6Q33877447-C7A3B829-EFB9-4918-8AFB-94BB16D6C539Q33886353-5CD6508E-B661-44BC-84EE-16E283C16516Q34733944-08A02652-E441-43AE-996E-B76062B60F2FQ34982142-BFFE3CAB-E653-4CC2-A2C7-C657BB6B4822Q35039285-824BFE1B-1D80-47C9-AFEC-EABA73791B14Q35076202-63DD7EF2-6761-471C-A0A6-5FEBC3B9C82EQ35200383-57551559-8851-43F4-85BC-2B9BB2D72795Q35537379-3CB6FC55-0D9D-49ED-8466-6AB8A8A0FB2CQ35627621-DF38ABAA-8C0E-4F5C-9B87-47E5C0ED6899Q35782899-4BF4658C-90F1-4C22-A670-E6528F4935D6Q35923256-F9902067-CE9D-4155-9774-239A695CE684Q36158717-28B0F183-3774-4199-B807-5C5ECE612F7EQ36195470-DD3C20DF-7A55-4A07-92CE-A77C3970996DQ36247875-B1692374-FCFE-48E7-8E32-7D291C239F00Q36296453-E4091890-A80C-416F-BB29-17916E4DFDCFQ36302496-029CFAEF-B7D8-478E-A15A-5D76789D1275Q36545344-28EA4692-E148-412F-B5DB-6F8274F65BD2Q36614079-18CD3D26-87F7-4699-AB27-3EF383F85B39Q36644057-1A4DFDB2-8F99-4E0A-A2B4-28D14D7CD754Q36785118-7C6F99D6-B9BD-41A2-8C10-7F655585E9A3Q36852163-D1515176-2717-4F19-AD2E-1D918C9BECEBQ37085999-AA84ACA2-4E0B-48A0-B68F-F77A7CCC3EFAQ37208623-95A97740-92A0-4F45-A750-F4271BEDEFB8Q37323898-04DB474B-1ED5-4211-93FD-D1C1E02C3354Q37478345-5C8DBA56-9675-4979-9397-5995F8E9C2C7Q37642455-CFD231C1-1463-4F56-A6CD-471903654294Q38263799-42E44E9F-4918-4B0E-B232-D45979598D07Q39034554-F4FB8AD6-8E6F-43C4-94A0-76B1F746DB24Q39572054-7FC79A43-4208-44CC-89BC-6520E80C18F0Q39754886-9A15C255-AA07-445C-BC23-4A4B9C678605Q40406773-30775437-B665-45B0-9E3E-2C2150409E6EQ40521275-D8DB70FE-7E4C-488E-ADF2-6B9B8AC15E54
P2860
Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Preresectional chemotherapy in ...... a randomized controlled trial
@ast
Preresectional chemotherapy in ...... a randomized controlled trial
@en
Preresectional chemotherapy in ...... a randomized controlled trial
@nl
type
label
Preresectional chemotherapy in ...... a randomized controlled trial
@ast
Preresectional chemotherapy in ...... a randomized controlled trial
@en
Preresectional chemotherapy in ...... a randomized controlled trial
@nl
prefLabel
Preresectional chemotherapy in ...... a randomized controlled trial
@ast
Preresectional chemotherapy in ...... a randomized controlled trial
@en
Preresectional chemotherapy in ...... a randomized controlled trial
@nl
P2093
P1433
P1476
Preresectional chemotherapy in ...... a randomized controlled trial
@en
P2093
J Gómez-Codina
J Javier Sánchez
P356
10.1016/S0169-5002(99)00045-8
P407
P577
1999-10-01T00:00:00Z